Global Bone Cancer Treatment Market to Reach $1.8 Billion by 2031: Says AMR

Rise in the prevalence of cancer, increase in government initiatives, and surge in product launch & product approval drive the growth of the global bone cancer treatment market. By drug type, the immunotherapy and targeted therapy segment held the major share in 2021. By region, on the other hand, the Asia-Pacific region would showcase the fastest CAGR by 2031.


Portland, OR, Oct. 21, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Bone Cancer Treatment Market was estimated at $1.2 billion in 2021 and is expected to hit $1.8 billion by 2031, registering a CAGR of 4.5% from 2022 to 2031. The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.

Download Free Sample Report (294 Pages PDF with Insights, Charts, Tables, Figures): https://www.alliedmarketresearch.com/request-sample/17969

Report coverage & details:

Report CoverageDetails
Forecast Period2022­–2031
Market Size in 2031$1.8 Billion
CAGR4.5%
No. of Pages in Report294
Drivers Rise in the prevalence of cancer
Increase in government initiatives and surge in product launch & product approval
OpportunitiesRise in government initiatives for bone cancer awareness


Covid-19 scenario-

  • Closure of the majority of healthcare facilities and serious concerns over the exposure of Covid-19 had a negative impact on the global bone cancer treatment market.
  • However, as the global situation started getting better, the market for bone cancer treatment also got back on track.

The global bone cancer treatment market is analyzed across type, end-use industry, and region. The report takes in an exhaustive analysis of segments and their sub-segments with the help of tabular and graphical representation. Investors and market players can benefit from the breakdown and devise stratagems based on the highest revenue-generating and fastest-growing segments stated in the report.

Based on type, the osteosarcoma segment held nearly three-fifths of the total market revenue in 2021, and is expected to dominate by 2031. The same segment would also manifest the fastest CAGR of 4.7% throughout the forecast period.

Purchase Inquiry:
https://www.alliedmarketresearch.com/purchase-enquiry/17969

Based on drug type, the immunotherapy and targeted therapy segment held more than two-thirds of the total market revenue in 2021, and is expected to dominate by 2031. The same segment would also manifest the fastest CAGR of 4.6% throughout the forecast period.

Based on distribution channel, the hospital pharmacies segment held more than half of the total market revenue in 2021, and is expected to dominate by 2031. The online pharmacies segment, however, would cite the fastest CAGR of 5.3% throughout the forecast period.

Based on region, the market across North America generated more than two-fifths of the global market revenue in 2021, and is anticipated to retain the lion’s share by 2031. The Asia-Pacific region, nevertheless, would manifest the fastest CAGR of 5.2% during the forecast period. The other provinces analyzed in the report include Europe and LAMEA.

The key market players analyzed in the global bone cancer treatment market report include Cancervax, Inc, Cellectar Biosciences, Inc, Pfizer, Inc, Advaxis, Inc, Isofol Medical Ab, Gradalis Inc, QSAM Biosciences, Inc., Takeda Pharmaceutical Company Limited, Hikma Pharmaceutical PLC, and Zentalis Pharmaceuticals. These market players have embraced several strategies including partnership, expansion, collaboration, joint ventures, and others to highlight their prowess in the industry. The report is helpful in formulating the business performance, product portfolio, operating segments, and developments by the top players.


Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Allergy Diagnostics Market by Test Type (In Vivo, In Vitro), by Product & Service (Consumables, Instruments, Services), by Allergen (Inhaled Allergens, Food Allergens, Drug Allergens, Other Allergens), by End-user (Diagnostic Laboratories, Hospital-based Laboratories, Academic Research Institutes, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

Breast Implants Market by Type (Silicone Implants, Saline Implants), by Shape (Round, Anatomical), by Texture (Smooth, Textured), by Application (Breast Augmentation, Breast Reconstruction), by End-use (Hospital, Clinics): Global Opportunity Analysis and Industry Forecast, 2021-2031

Medical Case Management Market by Service (Web-Based Case Management, Field Case Management, Bilingual Field Case Management, Telephonic Case Management), by Case (Chronic Pain Case Management, Independent Medical Examinations, Catastrophic Case Management, Long Term Disability, Short Term Disability), by End Users (Medical Case Management Providers, Healthcare Insurance Companies, Healthcare It Service Providers, Healthcare BPO & KPO Vendors, Corporate Entities, Healthcare Institutions, Venture Capitalists, Government Bodies, Accountable Care Organizations): Global Opportunity Analysis and Industry Forecast, 2021-2030

Fertility Test Market by Product (Ovulation Prediction Kits, Fertility Monitors, and Male Fertility Testing Products), Mode of Purchase (OTC-based and Prescription-based), Application (Female Fertility Testing and Male Fertility Testing), and End User (Home Care Settings and Hospitals/Fertility Clinics): Global Opportunity Analysis and Industry Forecast, 2021-2028

Precision Medicine Market by Technology (Genomics, Transcriptomics and Epigenomics), by Sequencing Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real Time Sequencing, Chain Termination Sequencing and Nanopore Sequencing), Product (Consumables, Instruments and Services) Application (Oncology, CNS, Immunology, Respiratory Medicine, Infections, and Other Applications) End User (Diagnostic Tool companies, Pharma & Biotech Companies, Clinical Laboratories, and Healthcare IT/Big Data Companies) - Global Opportunity Analysis and Industry Forecast, 2020-2030


About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.


Follow Us on Blog: https://www.globalhealthcareindustry.com/

 

Kontaktdaten